APA (7th ed.) Citation

Cros, J., Hentic, O., Rebours, V., Zappa, M., Gille, N., Theou-Anton, N., . . . Couvelard, A. (2016). MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors. Endocrine-Related Cancer, 23(8), 625. https://doi.org/10.1530/ERC-16-0117

Chicago Style (17th ed.) Citation

Cros, J., et al. "MGMT Expression Predicts Response to Temozolomide in Pancreatic Neuroendocrine Tumors." Endocrine-Related Cancer 23, no. 8 (2016): 625. https://doi.org/10.1530/ERC-16-0117.

MLA (9th ed.) Citation

Cros, J., et al. "MGMT Expression Predicts Response to Temozolomide in Pancreatic Neuroendocrine Tumors." Endocrine-Related Cancer, vol. 23, no. 8, 2016, p. 625, https://doi.org/10.1530/ERC-16-0117.